A leading COVID-19 vaccination study out of Oxford has been paused after one of its participants con-tracted an “unexplained illness.” Yesterday, pharmaceutical giant and partner of Oxford’s vaccination development AstraZeneca an-nounced in a statement that the illness “occurred in the UK Phase III trial.” The company has started an investigation, which it called a “standard […]
Source: Leadership Newspaper
